Neurocrine Biosciences Inc
XBER:NB3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neurocrine Biosciences Inc
XBER:NB3
|
US |
|
K
|
Koninklijke Philips NV
XBER:PHI1
|
NL |
|
G
|
Glenmark Life Sciences Ltd
BSE:543322
|
IN |
|
BW Energy Ltd
OTC:BWEFF
|
BM |
|
S
|
Swiss Life Holding AG
XHAM:SLW
|
CH |
|
F
|
Franklin Resources Inc
BMV:BEN
|
US |
|
Press Metal Aluminium Holdings Bhd
OTC:PSSMF
|
MY |
|
Lucid Group Inc
NASDAQ:LCID
|
US |
|
R
|
Ramsay Health Care Ltd
OTC:RMYHY
|
AU |
|
F
|
FirstEnergy Corp
XBER:FE7
|
US |
|
CTEEP Companhia de Transmissao de Energia Eletrica Paulista
BOVESPA:TRPL3
|
BR |
|
Bonheur ASA
F:V7P
|
NO |
|
C
|
Construction Partners Inc
F:CQY
|
US |
|
B
|
Blencowe Resources PLC
LSE:BRES
|
UK |
|
Eventbrite Inc
NYSE:EB
|
US |
|
Sandoz Group AG
F:D8Y0
|
CH |
|
NCC Ltd
BSE:500294
|
IN |
|
S
|
Softronic AB
SWB:SF7
|
SE |
|
M
|
Mineral Hill Industries Ltd
F:MLN
|
CA |
|
G
|
General Dynamics Corp
LSE:0IUC
|
US |
|
R
|
Reliance Infrastructure Ltd
LSE:RIFS
|
IN |
|
B
|
Barratt Developments P L C
XBER:3BA
|
UK |
|
H
|
HSBC Holdings PLC
F:HBC1
|
UK |
|
A
|
Arch Resources Inc
SWB:ACCA
|
US |
Bankruptcy Probability
Neurocrine Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Neurocrine Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Neurocrine Biosciences Inc
NASDAQ:NBIX
|
16.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Neurocrine Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Neurocrine Biosciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.
